Skip to main content
Journal cover image

GW572016, a novel dual EGFR/Her-2 small molecule, tyrosine kinase inhibitor induces regression and significant growth delay in tamoxifen-resistant, MCF-7 derived tumors.

Publication ,  Conference
Blackwell, K; Spector, N; Snyder, S; Marks, J; Broadwater, LH; McDonnell, D; Dewhirst, M; Xia, W; Liu, LH
Published in: BREAST CANCER RESEARCH AND TREATMENT
December 1, 2002

Duke Scholars

Published In

BREAST CANCER RESEARCH AND TREATMENT

ISSN

0167-6806

Publication Date

December 1, 2002

Volume

76

Start / End Page

S130 / S130

Location

SAN ANTONIO, TEXAS

Publisher

KLUWER ACADEMIC PUBL

Conference Name

25th San Antonio Breast Cancer Symposium

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Blackwell, K., Spector, N., Snyder, S., Marks, J., Broadwater, L. H., McDonnell, D., … Liu, L. H. (2002). GW572016, a novel dual EGFR/Her-2 small molecule, tyrosine kinase inhibitor induces regression and significant growth delay in tamoxifen-resistant, MCF-7 derived tumors. In BREAST CANCER RESEARCH AND TREATMENT (Vol. 76, pp. S130–S130). SAN ANTONIO, TEXAS: KLUWER ACADEMIC PUBL.
Blackwell, K., N. Spector, S. Snyder, J. Marks, L. H. Broadwater, D. McDonnell, M. Dewhirst, W. Xia, and L. H. Liu. “GW572016, a novel dual EGFR/Her-2 small molecule, tyrosine kinase inhibitor induces regression and significant growth delay in tamoxifen-resistant, MCF-7 derived tumors.” In BREAST CANCER RESEARCH AND TREATMENT, 76:S130–S130. KLUWER ACADEMIC PUBL, 2002.
Blackwell K, Spector N, Snyder S, Marks J, Broadwater LH, McDonnell D, et al. GW572016, a novel dual EGFR/Her-2 small molecule, tyrosine kinase inhibitor induces regression and significant growth delay in tamoxifen-resistant, MCF-7 derived tumors. In: BREAST CANCER RESEARCH AND TREATMENT. KLUWER ACADEMIC PUBL; 2002. p. S130–S130.
Blackwell, K., et al. “GW572016, a novel dual EGFR/Her-2 small molecule, tyrosine kinase inhibitor induces regression and significant growth delay in tamoxifen-resistant, MCF-7 derived tumors.BREAST CANCER RESEARCH AND TREATMENT, vol. 76, KLUWER ACADEMIC PUBL, 2002, pp. S130–S130.
Blackwell K, Spector N, Snyder S, Marks J, Broadwater LH, McDonnell D, Dewhirst M, Xia W, Liu LH. GW572016, a novel dual EGFR/Her-2 small molecule, tyrosine kinase inhibitor induces regression and significant growth delay in tamoxifen-resistant, MCF-7 derived tumors. BREAST CANCER RESEARCH AND TREATMENT. KLUWER ACADEMIC PUBL; 2002. p. S130–S130.
Journal cover image

Published In

BREAST CANCER RESEARCH AND TREATMENT

ISSN

0167-6806

Publication Date

December 1, 2002

Volume

76

Start / End Page

S130 / S130

Location

SAN ANTONIO, TEXAS

Publisher

KLUWER ACADEMIC PUBL

Conference Name

25th San Antonio Breast Cancer Symposium

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences